Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

25.36
+0.20000.79%
Post-market: 25.360.00000.00%19:30 EDT
Volume:538.04K
Turnover:13.66M
Market Cap:1.01B
PE:72.09
High:25.57
Open:25.43
Low:25.18
Close:25.16
52wk High:27.66
52wk Low:18.80
Shares:39.86M
Float Shares:36.37M
Volume Ratio:0.97
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3518
EPS(LYR):0.1578
ROE:2.05%
ROA:1.48%
PB:1.50
PE(LYR):160.68

Loading ...

ISS urges Pacira holders to back management slate, reject DOMA push to sell company at June 9 meeting

Reuters
·
Jun 02

Press Release: Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees

Dow Jones
·
Jun 02

Glass Lewis recommends shareholders vote for Pacira director nominees

TIPRANKS
·
May 29

Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "for" All of Pacira's Director Nominees

THOMSON REUTERS
·
May 29

Press Release: Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "FOR" All of Pacira's Director Nominees

Dow Jones
·
May 29

Pacira urges vote for board slate as DOMA seeks to replace three director nominees ahead of June 9 meeting

Reuters
·
May 28

Pacira Biosciences Inc - Urges Stockholders to Vote "for" Election of Pacira's Nominees on Blue Proxy Card

THOMSON REUTERS
·
May 28

Press Release: Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees

Dow Jones
·
May 28

Pacira study shows Exparel reduces opioid use and costs

TIPRANKS
·
May 27

Pacira BioSciences Says Exparel Linked to Lower Opioid Use, Healthcare Costs

MT Newswires Live
·
May 27

Pacira says real-world study links EXPAREL to lower opioid use after outpatient shoulder replacement

Reuters
·
May 27

Pacira Biosciences Reports Real-World Study Showing Exparel® Use Was Associated With Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

THOMSON REUTERS
·
May 27

Pacira issues statement on DOMA’s ‘misleading’ statements

TIPRANKS
·
May 26

Pacira rebuts DOMA claims on EXPAREL intellectual property strategy

Reuters
·
May 26

Pacira urges vote for board nominees, rebuts activist DOMA criticism of Exp​​arel IP strategy

Reuters
·
May 26

BRIEF-Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy

Reuters
·
May 22

Doma Perpetual - Shareholders Should Decide IF Sale Price the Co Finds Through Disciplined, Board‑Supervised Process Is Adequate & in Best Interests

THOMSON REUTERS
·
May 22

Pacira activist DOMA urges vote for its nominees, presses strategic alternatives ahead of June 9 meeting

Reuters
·
May 22

Pacira Biosciences posts investor presentation ahead of annual meeting

Reuters
·
May 20

Pacira urges vote for its directors as activist DOMA seeks CEO ouster, company sale

Reuters
·
May 20